GUOHONG SHAO: Open Payments
NPI 1689194870 · COLUMBUS, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$290 in 11 payments from 7 companies in 2025. Trend: 2023 $24 · 2024 $123 · 2025 $290
Food & beverage: $288Education: $2
| Company | Payments | Amount |
|---|---|---|
| AKEBIA THERAPEUTICS INC | 3 | $74 |
| Fresenius USA Marketing, Inc. | 1 | $69 |
| ANI Pharmaceuticals, Inc. | 3 | $60 |
| Calliditas Therapeutics US Inc. | 1 | $30 |
| Otsuka America Pharmaceutical, Inc. | 1 | $28 |
| Novartis Pharmaceuticals Corporation | 1 | $26 |
| Travere Therapeutics, Inc. | 1 | $2 |
Products named: VELPHORO, PURIFIED CORTROPHIN GEL, Vafseo, TARPEYO, JYNARQUE, Fabhalta, Auryxia, Filspari.
Industry payments across OH — which companies pay providers there.
